Carregant...
Nexrutine(®) preserves muscle mass similar to exercise in prostate cancer mouse model
Muscle loss is a debilitating side effect to prostate cancer (PCa) experienced by nearly 60% of men. The purpose of this study was to test the hypothesis that Nexrutine(®), a bark extract from the Phellodendrum amurense, can protect against prostate cancer induced muscle loss in a similar manner as...
Guardat en:
| Publicat a: | Physiol Rep |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6712237/ https://ncbi.nlm.nih.gov/pubmed/31456341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.14217 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|